ストックスクリーナーアプリを入手
70.48
2.32%
1.60
前日終値:
$68.88
開ける：
$70
24時間の取引高:
908.87K
Relative Volume:
0.73
時価総額：
$12.22B
収益：
$8.35B
当期純損益:
$1.56B
株価収益率:
7.9425
EPS:
8.8738
ネットキャッシュフロー:
$-4.00M
1週間 パフォーマンス:
+7.13%
1か月 パフォーマンス:
+2.64%
6か月 パフォーマンス:
-2.33%
1年 パフォーマンス:
+6.37%
1日の値動き範囲:
$69.78
$71.42
1週間の範囲:
$65.13
$71.42
52週間の値動き範囲:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
70.48 | 12.22B | 8.35B | 1.56B | -4.00M | 8.8738 |
ISRG
Intuitive Surgical Inc
|
469.21 | 166.65B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.54 | 45.10B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
81.32 | 39.64B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.64 | 38.67B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.12 | 33.23B | 5.40B | 1.49B | 1.78B | 10.12 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-24 | 開始されました | Rothschild & Co Redburn | Sell |
| 2026-01-26 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | アップグレード | Mizuho | Neutral → Outperform |
| 2025-12-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-10-01 | 開始されました | UBS | Neutral |
| 2025-09-11 | 開始されました | Jefferies | Hold |
| 2025-07-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | アップグレード | Argus | Hold → Buy |
| 2025-06-06 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-10-08 | 開始されました | Stifel | Buy |
| 2024-10-07 | 開始されました | Piper Sandler | Neutral |
| 2024-09-26 | 開始されました | Wolfe Research | Peer Perform |
| 2024-09-05 | 開始されました | BTIG Research | Neutral |
| 2024-06-24 | 開始されました | Argus | Hold |
| 2024-05-30 | 開始されました | Goldman | Sell |
| 2024-05-10 | 開始されました | BofA Securities | Neutral |
| 2024-04-10 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 開始されました | Wells Fargo | Equal Weight |
| 2024-04-02 | 開始されました | Edward Jones | Hold |
すべてを表示
Solventum Corp (SOLV) 最新ニュース
Here's why you should hold Solventum stock in your portfolio now - MSN
Ensemble and Solventum to launch autonomous coding solution for hospitals - MSN
Why Solventum (SOLV) is a top value stock for the long term - MSN
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Piper Sandler Adjusts Solventum PT to $92 From $98, Maintains Overweight Rating - marketscreener.com
Piper Sandler cuts Solventum stock price target on model updates - Investing.com
Solventum Corporation (NYSE:SOLV) Short Interest Update - MarketBeat
Piper Sandler cuts Solventum stock price target on model updates By Investing.com - Investing.com Canada
Solventum Corporation $SOLV Shares Acquired by KBC Group NV - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $23.70 Million Stock Position in Solventum Corporation $SOLV - MarketBeat
Why The Solventum (SOLV) Story Is Shifting As Analyst Targets And Assumptions Reset - Yahoo Finance
Minnesota’s Solventum to pay $1.6M fine for selling equipment to Chinese firms - MSN
3M vs. United Parcel Service: One of These Industrial Stocks Is a Much Better Buy Right Now - The Motley Fool
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Assessing Solventum (SOLV) Valuation After Mixed Quarterly Results And A Sharp Market Reaction - simplywall.st
Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, - GuruFocus
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026 - marketscreener.com
3 Reasons to Sell SOLV and 1 Stock to Buy Instead - The Globe and Mail
Is Solventum (SOLV) Unlocking Hidden Value With Its MedSurg-Focused Portfolio Simplification Strategy? - simplywall.st
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Surgical Devices and SuppliesQ4 Review of Diversified Holdings: Comparing Solventum (NYSE:SOLV) to Peers - Bitget
Surgical Equipment & ConsumablesDiversified Stocks Q4 Recap: Benchmarking Solventum (NYSE:SOLV) - Yahoo Finance
Market Pulse: Is Solventum Corporation attractive for institutional investorsIndex Update & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Cambiar Investors LLC Takes $4.46 Million Position in Solventum Corporation $SOLV - MarketBeat
Solventum healthcare company expands its Brookings facility - MSN
Solventum Fined $1.6M Over Sales To Chinese Firms - Hoodline
Independent Franchise Partners US Equity Fund's Solventum Corp(SOLV) Holding History - GuruFocus
Solventum Corp. stock rises Thursday, outperforms market - MarketWatch
Here's why Solventum (SOLV) is a strong value stock - MSN
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Article: 3M healthcare spinoff reaches BIS settlement for China shipmentsGIR Just Sanctions - Global Investigations Review
US Commerce settles with Solventum over Entity List sale allegations - MLex
Solventum’s Debt Reduction and Financial Restructuring: Has the Optimistic Outlook Been Fully Valued? - Bitget
Solventum: A Hidden Breakup Story In Healthcare(NYSE:SOLV) - Seeking Alpha
Solventum Corporation (SOLV) stock price, news, quote and history - Yahoo Finance Singapore
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum CAO Retirement Puts Focus On Controls And Execution Risks - Yahoo Finance
Solventum celebrates major expansion in Brookings - Brookings Register
Can Solventum Tackle AI Competition in HIS Market? - Medical Device and Diagnostic industry
Solventum stock maintained at Buy by BTIG on AI impact analysis - Investing.com India
Solventum’s US$200 Million Innovation Hub and CAO Transition Might Change The Case For Investing In Solventum (SOLV) - simplywall.st
Solventum Corporation (NYSE:SOLV) Receives Average Rating of "Hold" from Analysts - MarketBeat
SOLV Technical Analysis & Stock Price Forecast - Intellectia AI
The Week in Business: Solventum Opens $200M R&D Facility in Eagan - Mpls.St.Paul Magazine
Solventum Corp (SOLV) 財務データ
収益
当期純利益
現金流量
EPS
2.73%
大文字化:
|
ボリューム (24 時間):